Home › Opioid Overdose › NCT06969261
Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Who can join
All ages · Women
Full eligibility criteria
Inclusion Criteria: * Biological females who are currently pregnant or within 6 weeks postpartum. * Able to read, write, and speak English at a 6th grade level. * Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder. * Receiving prenatal care and OUD care at a Penn affiliated hospital. Exclusion Criteria: -Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI).
About the study
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.
What is being tested
- Penny COPILOT (behavioral)
Sponsor: University of Pennsylvania · Participants: 20 · Started: Jan 1, 2026
Contact the study team
- Sara L Kornfield, PhD · Phone: 1-800-789-7366
Official record on ClinicalTrials.gov — NCT06969261
Locations in the U.S.
| Pennsylvania | Hospital of the University of Pennsylvania (HUP), Philadelphia University of Pennsylvania, Philadelphia (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.